暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
暂无内容
Cogent报告了阳性的癌症组合治疗试验数据;任命了商业负责人
Cogent Biosciences(COGT)周四表示,正在进行的bezuclastinib和舒尼替尼组合的3期试验的新前导数据显示,有可能成为晚期胃炎的新护理标准
快讯 | Cogent Biosciences在ASCO年会上报告了正在进行的3期PEAK试验的最新先导数据
Cogent Biosciences-宣布由Sarc与Life Raft集团和达纳-法伯癌症研究所合作赞助的新Advanced Gist临床试验
Cogent Biosciences-宣布由Sarc与Life Raft集团和达纳-法伯癌症研究所合作赞助的新Advanced Gist临床试验
Cogent Biosciences Inc——第三阶段的峰值指导加快了现在预计注册将于2024年第三季度完成
Cogent Biosciences Inc——第三阶段的峰值指导加快了现在预计注册将于2024年第三季度完成
快讯 | Cogent Biosciences 任命 Cole Pinnow 为首席商务官
快讯 | Cogent Biosciences Inc——将Bezuclastinib加入舒尼替尼的总体耐受性仍然良好,安全性令人鼓舞
Jaguar8 : I remember detecting a gastro CA as young as 25, referred to onco after CT, and such aggressiveness killed him in less than a year.
Trytosaveabit楼主 Jaguar8: So sad! If it woulda been found sooner could a bit more time been had? Or in this case it wouldn’t have made a difference?
Jaguar8 Trytosaveabit楼主: This type of cancer is usually diagnosed in advanced stage and a very aggressive one
Trytosaveabit楼主 Jaguar8: Yeah! Sad! BTW all the BIO PR released this evening! I’m really digging the INAB especially with how close they seem to be getting to end of phase?
Jaguar8 Trytosaveabit楼主: Yes INAB study is very interesting!